Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Fahed, Darmoch"'
Autor:
Mohamad Soud, Yasser Al-khadra, Fahed Darmoch, Homam Moussa Pacha, Zaher Fanari, M Chadi Alraies
Publikováno v:
Avicenna Journal of Medicine, Vol 10, Iss 01, Pp 22-28 (2020)
Background: Bicuspid aortic valve (BAV) disease is considered the most common congenital heart disease and the main etiology of aortic valve stenosis (AS) in young adults. Although transcatheter aortic valve replacement (TAVR) is routinely used in hi
Externí odkaz:
https://doaj.org/article/bd1ce2a9eda04102bd93f659aa2e1f09
Autor:
Waqas Ullah, Yasar Sattar, Fahed Darmoch, Yasser Al-khadra, Tanveer Mir, Rasikh Ajmal, Homam Moussa-Pacha, James Glazier, Abedelrahim Asfour, Delair Gardi, M. Chadi Alraies
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 28, Iss , Pp 100509- (2020)
Background: Left ventricular assist devices (LVAD) are indicated as bridging or destination therapy for patients with advanced (Stage D) heart failure and reduced ejection fraction (HFrEF). Due to the clustering of the mutual risk factors, HFrEF pati
Externí odkaz:
https://doaj.org/article/3f9c5e383046463b81f890d368c7191c
Autor:
Fahed Darmoch, M. Chadi Alraies, Yasser Al‐Khadra, Homam Moussa Pacha, Duane S. Pinto, Eric A. Osborn
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 5 (2020)
Background Intravascular ultrasound (IVUS) guidance during percutaneous coronary intervention (PCI) offers tomographic images of the coronary vessels, allowing optimization of stent implantation at the time of PCI. However, the long‐term beneficial
Externí odkaz:
https://doaj.org/article/a85968b5505d4025b4bb4aa1e4f77256
Publikováno v:
Avicenna Journal of Medicine, Vol 9, Iss 02, Pp 86-88 (2019)
Externí odkaz:
https://doaj.org/article/f083b87c7e7b4f189fe1e4a6cd884965
Autor:
Fahed Darmoch, Matthew Gottbrecht
Publikováno v:
Journal of the American College of Cardiology. 81:3184
Autor:
Allan L. Klein, Waqas Ullah, Fahed Darmoch, Ghaith Alhatemi, Tanveer Mir, Zaher Hakim, Mohamad Soud, Marvin Kajy, Yasser Al-Khadra, Mohamed Zghouzi, Ali Banisad, Homam Moussa Pacha, Yasar Sattar, M. Chadi Alraies, Fnu Zafrullah
Publikováno v:
Expert Review of Cardiovascular Therapy. 19:261-268
Background: The 30-day readmission risk factors for acute pericarditis are not well known. We investigated the risk factors and predictors of pericarditis from a national cohort. Methods: Readmissi...
Autor:
Omar E. Ali, M. Chadi Alraies, Waqas Ullah, Fahed Darmoch, Zaher Hakim, Mohamad Soud, Ziad SayedAhmad, Yasser Al-Khadra, Yasar Sattar, Ali Bani Saad, Homam Moussa Pacha, Fred King, James J. Glazier, Fares Alahdab, Marvin Kajy, Ghaith Alhatemi
Publikováno v:
Expert Review of Cardiovascular Therapy. 18:809-817
The clinical efficacy and safety of transradial (TR) percutaneous coronary intervention (PCI) in comparison to transfemoral (TF) for chronic total occlusion (CTO) is not well studied in literature.After a systematic literature search was done in PubM
Autor:
Zaher Fanari, Homam Moussa Pacha, M. Chadi Alraies, Yasser Al-Khadra, Fahed Darmoch, Mohamad Soud
Publikováno v:
Avicenna Journal of Medicine, Vol 10, Iss 01, Pp 22-28 (2020)
Avicenna Journal of Medicine
Avicenna Journal of Medicine
Background: Bicuspid aortic valve (BAV) disease is considered the most common congenital heart disease and the main etiology of aortic valve stenosis (AS) in young adults. Although transcatheter aortic valve replacement (TAVR) is routinely used in hi
Autor:
Andrew M. Goldsweig, Mohamad Soud, Yasser Al-Khadra, Rodrigo Bagur, Emmanouil S. Brilakis, Homam Moussa Pacha, Mamas A. Mamas, M. Chadi Alraies, Srihari S. Naidu, Waqas Ullah, Fahed Darmoch, Mohamed Zghouzi, Yasar Sattar
Publikováno v:
Expert review of cardiovascular therapy. 19(9)
Suboptimal stent delivery and deployment in calcified coronary lesions are associated with a poor clinical outcome.Using the National Inpatient Sample database, we identified patients undergoing percutaneous coronary intervention (PCI). Comparison be
Autor:
Mohamad Soud, Homam Moussa Pacha, Fahed Darmoch, Yasser Al-Khadra, Amir Kaki, Samir R. Kapadia, M. Chadi Alraies
Publikováno v:
JACC: Cardiovascular Interventions. 13:270-272
Since the approval of transcatheter aortic valve replacement (TAVR) in 2011 by the U.S. Food and Drug Administration, the use of TAVR has been steadily increasing [(1)][1]. Although previous data showed no difference in the outcomes of TAVR compared